Specialty: Injuries and emergencies, Primary sub-specialty: Musculoskeletal Trauma
Conditions
Interventions
There will be four hospitals participating in the trial, which will be run using a stepped wedge design. In this design, all hospitals will commence data collection at the same time, as the control ar
Sponsors
ABMU Health Board
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis of isolated blunt chest wall trauma 2. Aged 18 and over 3. Capable of giving consent to participation 4. Male or female 5. Presenting to the Emergency Department of participating hospital
Exclusion criteria
Exclusion criteria: 1. Patients under the age of 18 years 2. Patients who lack capacity to give informed consent, 3. Patients with any immediately life-threatening injuries 4. Patients with any concurrent injury that will determine the patient’s management (rather than the chest trauma)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient recruitment rate will be recorded as the number of eligible patients who consent to trial participation at the end of the five month data collection period, at each site. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Clinician recruitment rate will be recorded as the number of eligible clinicians working within the participating ED who agree to take part in the study by the end of the five month data collection period, at each site 2. Response rate of follow up data (quality of life surveys) will be recorded as the number of patients returning postal surveys at the end of the five month data collection period, at each site 3. Clinicians Training Attendance rate will be recorded as the number of clinicians receive formal training in the use of the model, prior to the second data collection period (treatment arm), at each site 4. Compliance with use of model rate will be recorded as the number of times the clinician used the risk model for an eligible patient, at the end of the second month data collection period (treatment arm) 5. Overall mean quality of life as reported using the SF-12v2 survey for patients, at the end of the control (end of month two) and treatment (end of month five) data collection periods, at each participating site 6. Resource usage by patients as a results of the intervention as reported on the Client Service Receipt Inventory at six week follow-up | — |
Countries
United Kingdom
Contacts
Public ContactCeri Battle
Outcome results
None listed